Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955028 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Syndecan 3 (SDC3) (AA 411-442), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column followed by peptide Affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term, AA 411-442
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism.
Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis.
The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.
Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions.
Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism.
Schüring AN, Lutz F, Tüttelmann F, Gromoll J, Kiesel L, Götte M
Journal of molecular medicine (Berlin, Germany) 2009 Dec;87(12):1241-50
Journal of molecular medicine (Berlin, Germany) 2009 Dec;87(12):1241-50
Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis.
Yao J, Ma Q, Wang L, Zhang M
Digestive diseases and sciences 2009 Apr;54(4):895-901
Digestive diseases and sciences 2009 Apr;54(4):895-901
The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.
Landgraf P, Wahle P, Pape HC, Gundelfinger ED, Kreutz MR
The Journal of biological chemistry 2008 Sep 5;283(36):25036-45
The Journal of biological chemistry 2008 Sep 5;283(36):25036-45
Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions.
Dews IC, Mackenzie KR
Proceedings of the National Academy of Sciences of the United States of America 2007 Dec 26;104(52):20782-7
Proceedings of the National Academy of Sciences of the United States of America 2007 Dec 26;104(52):20782-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
